Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
GBD 2013 Mortality and Causes of Death Collaborators (2015).  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.. Lancet. 385(9963), 117-71.
Murray, C. J. L., Barber R. M., Foreman K. J., Ozgoren A. Abbasoglu, Abd-Allah F., Abera S. F., et al. (2015).  Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.. Lancet. 386(10009), 2145-91.
Gbandi, E., Goulas A., Sevastianos V., Hadziyannis S., Panderi A., Koskinas J., et al. (2016).  Common ABCB1 polymorphisms in Greek patients with chronic hepatitis C infection: A comparison with hyperlipidemic patients and the general population.. Pharmacol Rep. 68(2), 476-82.
Gazzaruso, C., Gola M., Karamouzis I., Giubbini R., & Giustina A. (2014).  Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update.. J Clin Endocrinol Metab. 99(1), 18-29.
Gazi, A. D., Charova S., Aivaliotis M., Panopoulos N. J., & Kokkinidis M. (2015).  HrpG and HrpV proteins from the Type III secretion system of Erwinia amylovora form a stable heterodimer. FEMS Microbiology Letters. 362(1), 1 - 8.
Gavriilidis, G. I., Ntoufa S., Papakonstantinou N., Kotta K., Koletsa T., Chartomatsidou E., et al. (2020).  Stem cell factor Is implicated In microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemia.. Haematologica.
Gavriilidis, P., Giakoustidis A., & Giakoustidis D. (2015).  Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review.. J Clin Med Res. 7(10), 742-51.
Gavriilidis, P., Poutahidis T., Giakoustidis A., Makedou K., Angelopoulou K., Hardas A., et al. (2018).  Targeting hepatocarcinogenesis model in C56BL6 mice with pan-aurora kinase inhibitor Danusertib.. J Cancer. 9(5), 914-922.
Gavriilaki, E., Kirmizis D., & Chatzidimitriou D. (2013).  Letter by Gavriilaki et al regarding article, "Bacterial signatures in thrombus aspirates of patients with myocardial infarction".. Circulation. 128(15), e236.
Gavriilaki, E., Christodoulou I., Koravou E-E., Paleta A., Koutra M., Zerva P., et al. (2018).  Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia.. Hemasphere. 2(5), e58.
Gavriilaki, E., Gkaliagkousi E., Nikolaidou B., Triantafyllou G., Chatzopoulou F., & Douma S. (2014).  Increased thrombotic and impaired fibrinolytic response to acute exercise in patients with essential hypertension: the effect of treatment with an angiotensin II receptor blocker.. J Hum Hypertens. 28(10), 606-9.
Gavriilaki, E., Asteris P. G., Touloumenidou T., Koravou E-E., Koutra M., Papayanni P. Georgia, et al. (2021).  Genetic justification of severe COVID-19 using a rigorous algorithm.. Clin Immunol. 226, 108726.
Gavriilaki, E., Gkaliagkousi E., Nikolaidou B., & Douma S. (2013).  Does vitamin D really contribute to excess cardiovascular risk in rheumatoid arthritis? Comment on the article by Haque et al.. Arthritis Care Res (Hoboken). 65(7), 1203.
Gavriilaki, E., Gkaliagkousi E., & Douma S. (2015).  Platelets interplay between pneumonia and cardiovascular events: establishing a link?. J Am Coll Cardiol. 65(14), 1487-8.
Gavriilaki, M., Mainou M., Gavriilaki E., Haidich A-B., Papagiannopoulos S., Sakellari I., et al. (2019).  Neurologic complications after allogeneic transplantation: a meta-analysis.. Ann Clin Transl Neurol. 6(10), 2037-2047.
Gavriilaki, E., Chatzidimitriou D., Chatzopoulou F., Gkaliagkousi E., & Douma S. (2013).  Pathogen burden and hypertension: more questions than answers.. Am J Hypertens. 26(12), 1459.
Gavriilaki, E., Mainou M., Christodoulou I., Koravou E-E., Paleta A., Touloumenidou T., et al. (2017).   evidence of complement activation in patients with sickle cell disease.. Haematologica. 102(12), e481-e482.
Gavriilaki, E., Sabanis N., Paschou E., Kalaitzoglou A., Michalaki K., & Zarampoukas T. (2015).  Disseminated tuberculosis: A neglected entity in immunocompromised hemodialysis patients.. Hemodial Int. 19(3), E8-E11.
Gavriilaki, E., Gkaliagkousi E., Nikolaidou B., & Douma S. (2015).  Mean platelet volume in hypertensive urgencies and emergencies: opening the Pandora's Box.. Platelets. 26(3), 275-6.
Gavriilaki, E., Tsiftsoglou S. A., Touloumenidou T., Farmaki E., Panagopoulou P., Michailidou E., et al. (2022).  Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection.. Curr Issues Mol Biol. 44(7), 2811-2824.
Gavriilaki, E., Sabanis N., Paschou E., Grigoriadis S., Mainou M., Gaitanaki A., et al. (2013).  Splenic infarction as a rare complication of infectious mononucleosis due to Epstein-Barr virus infection in a patient with no significant comorbidity: case report and review of the literature.. Scand J Infect Dis. 45(11), 888-90.
Gavriilaki, E., Gkaliagkousi E., & Douma S. (2015).  Visit-to-visit blood pressure variability: more to come.. J Clin Hypertens (Greenwich). 17(2), 116-7.
Gavriatopoulou, M., Kastritis E., Ntanasis-Stathopoulos I., Fotiou D., Roussou M., Migkou M., et al. (2018).  The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents.. Blood. 131(4), 464-467.
Gavriatopoulou, M., Kastritis E., Kyrtsonis M-C., Vassilakopoulos T. P., Roussou M., Fotiou D., et al. (2017).  Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia.. Leuk Lymphoma. 58(6), 1506-1508.
Gaveikaite, V., Grundstrom C., Winter S., Chouvarda I., Maglaveras N., & Priori R. (2019).  A systematic map and in-depth review of European telehealth interventions efficacy for chronic obstructive pulmonary disease.. Respir Med. 158, 78-88.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές